Neo Ivy Capital Management - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2022$22,000
+144.4%
514
+339.3%
0.02%
+100.0%
Q3 2021$9,000
-75.0%
117
-71.0%
0.01%
-75.0%
Q4 2020$36,000
+500.0%
403
+560.7%
0.04%
+566.7%
Q3 2020$6,000
-33.3%
61
-47.9%
0.01%
+100.0%
Q2 2020$9,000
-71.9%
117
-79.1%
0.00%
-94.2%
Q1 2020$32,000
-94.1%
559
-94.8%
0.05%
-83.0%
Q1 2019$539,000
+37.2%
10,683
+61.0%
0.31%
-1.0%
Q4 2018$393,0006,6350.31%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders